Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre pha... by Trappe, Ralf, Dr, Oertel, Stephan, MD, Leblond, Veronique, Prof, Mollee, Peter, MBBS, Sender, Monica, MD, Reinke, Petra, Prof, Neuhaus, Ruth, MD, Lehmkuhl, Hans, MD, Horst, Heinz August, Prof, Salles, Gilles, Prof, Morschhauser, Franck, MD, Jaccard, Arnaud, Prof, Lamy, Thierry, Prof, Leithäuser, Malte, MD, Zimmermann, Heiner, MB BChir, Anagnostopoulos, Ioannis, Prof, Raphael, Martine, Prof, Riess, Hanno, Prof, Choquet, Sylvain, MD

Get full text

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase... by Récher, Christian, Prof, Coiffier, Bertrand, Prof, Haioun, Corinne, Prof, Molina, Thierry Jo, Prof, Fermé, Christophe, MD, Casasnovas, Olivier, MD, Thiéblemont, Catherine, Prof, Bosly, André, Prof, Laurent, Guy, Prof, Morschhauser, Franck, MD, Ghesquières, Hervé, MD, Jardin, Fabrice, Prof, Bologna, Serge, MD, Fruchart, Christophe, MD, Corront, Bernadette, MD, Gabarre, Jean, MD, Bonnet, Christophe, MD, Janvier, Maud, MD, Canioni, Danielle, Prof, Jais, Jean-Philippe, MD, Salles, Gilles, Prof, Tilly, Hervé, Dr, Prof

Get full text

Radioimmunotherapy in follicular lymphoma by Illidge, Tim, Morschhauser, Franck, MD, PhD

Get full text

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomis... by Zelenetz, Andrew D, Prof, Barrientos, Jacqueline C, MD, Brown, Jennifer R, MD, Coiffier, Bertrand, Prof, Delgado, Julio, MD, Egyed, Miklós, Prof, Ghia, Paolo, MD, Illés, Árpád, Prof, Jurczak, Wojciech, MD, Marlton, Paula, MBBS, Montillo, Marco, MD, Morschhauser, Franck, Prof, Pristupa, Alexander S, MD, Robak, Tadeusz, Prof, Sharman, Jeff P, MD, Simpson, David, MBChB, Smolej, Lukáš, MD, Tausch, Eugen, MD, Adewoye, Adeboye H, MD, Dreiling, Lyndah K, MD, Kim, Yeonhee, PhD, Stilgenbauer, Stephan, Prof, Hillmen, Peter, Prof

Get full text

Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1... by Palanca-Wessels, Maria Corinna A, Dr, Czuczman, Myron, Prof, Salles, Gilles, Prof, Assouline, Sarit, MD, Sehn, Laurie H, MD, Flinn, Ian, MD, Patel, Manish R, MD, Sangha, Randeep, MD, Hagenbeek, Anton, MD, Advani, Ranjana, MD, Tilly, Herve, Prof, Casasnovas, Olivier, MD, Press, Oliver W, Prof, Yalamanchili, Sreeni, PharmD, Kahn, Robert, MD, Dere, Randall C, BSc, Lu, Dan, PhD, Jones, Surai, MS, Jones, Cheryl, ScD, Chu, Yu-Waye, MD, Morschhauser, Franck, Prof

Get full text

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymp... by Younes, Anas, Prof, Thieblemont, Catherine, Prof, Morschhauser, Franck, Prof, Flinn, Ian, MD, Friedberg, Jonathan W, Prof, Amorim, Sandy, MD, Hivert, Benedicte, MD, Westin, Jason, MD, Vermeulen, Jessica, MD, Bandyopadhyay, Nibedita, PhD, de Vries, Ronald, MSc, Balasubramanian, Sriram, PhD, Hellemans, Peter, MD, Smit, Johan W, PhD, Fourneau, Nele, Oki, Yasuhiro, MD

Get full text

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial by Ribrag, Vincent, Dr, Koscielny, Serge, PhD, Bosq, Jacques, MD, Leguay, Thibaut, Casasnovas, Olivier, MD, Fornecker, Luc-Mathieu, Recher, Christian, Ghesquieres, Hervé, MD, Morschhauser, Franck, Prof, Girault, Stéphane, MD, Gouill, Steven Le, Prof, Ojeda-Uribe, Mario, MD, Mariette, Clara, MD, Cornillon, Jerome, MD, Cartron, Guillaume, Prof, Verge, Veronique, MD, Chassagne-Clément, Catherine, MD, Dombret, Hervé, Prof, Coiffier, Bertrand, Prof, Lamy, Thierry, Prof, Tilly, Hervé, Prof, Salles, Gilles, Prof

Get full text

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial by Trněný, Marek, Prof, Lamy, Thierry, Prof, Walewski, Jan, Prof, Belada, David, MD, Mayer, Jiri, MD, Radford, John, Prof, Jurczak, Wojciech, MD, Morschhauser, Franck, Prof, Alexeeva, Julia, MD, Rule, Simon, Prof, Afanasyev, Boris, Prof, Kaplanov, Kamil, MD, Thyss, Antoine, Prof, Kuzmin, Alexej, MD, Voloshin, Sergey, MD, Kuliczkowski, Kazimierz, Prof, Giza, Agnieszka, MD, Milpied, Noel, Prof, Stelitano, Caterina, MD, Marks, Reinhard, MD, Trümper, Lorenz, Prof, Biyukov, Tsvetan, MD, Patturajan, Meera, PhD, Bravo, Marie-Laure Casadebaig, MSc, Arcaini, Luca, Prof

Get full text